CLL cell viability increased upon ET-1 stimulation, from 21%±11% in untreated CLL to 35%±12% in ET-1 treated CLL cells (p = 0.0008, Figure 2B). This evidence concerns the gene EDN1 and B-cell chronic lymphocytic leukemia.